Reaction
Perforation reporting signals
As of the last recalculation, Perforation appears in 785 FAERS reports alongside 32 co-occurring drug terms. The strongest observed disproportionality signal is PSEUDOEPHEDRINE HYDROCHLORIDE (PRR 47.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pseudoephedrine Hydrochloride | 18 | 47.5 | 47.6 |
| Pseudoephedrine Hcl | 18 | 44.3 | 44.4 |
| Tofacitinib Citrate | 20 | 41.5 | 41.5 |
| Cortisone Acetate | 18 | 39.5 | 39.6 |
| Phenobarbital | 17 | 31.8 | 31.8 |
| Tranexamic Acid | 10 | 30.2 | 30.2 |
| Liothyronine Sodium | 9 | 27.7 | 27.7 |
| Bevacizumab | 108 | 26.7 | 26.7 |
| Desoximetasone | 18 | 25.6 | 25.6 |
| Piperacillin And Tazobactam | 12 | 25.2 | 25.3 |
| Naproxen Sodium Tablet, Coated | 12 | 23.8 | 23.9 |
| Naproxen Sodium, Coated Tablets | 12 | 23.8 | 23.9 |
| Naproxen Sodium 220Mg | 12 | 23.8 | 23.8 |
| Midazolam Hydrochloride | 23 | 23.3 | 23.3 |
| Phenytoin | 17 | 22.1 | 22.1 |
| Piperacillin Sodium,Tazobactam Sodium | 20 | 20.5 | 20.5 |
| Norepinephrine | 8 | 20.0 | 20.1 |
| Sarilumab | 19 | 19.5 | 19.5 |
| Oxaliplatin | 44 | 16.6 | 16.6 |
| Propofol | 21 | 15.6 | 15.6 |
| Regorafenib | 6 | 13.8 | 13.8 |
| Lenvatinib | 16 | 13.2 | 13.2 |
| Fluorouracil Cream, 0.5% | 36 | 13.1 | 13.1 |
| Fluorouracil | 36 | 12.9 | 12.9 |
| Irinotecan Hydrochloride | 6 | 12.5 | 12.5 |
| Pertuzumab | 12 | 11.9 | 11.9 |
| Isopropyl Alcohol | 14 | 11.2 | 11.2 |
| Alcohol | 14 | 9.7 | 9.7 |
| Ustekinumab | 33 | 8.9 | 8.9 |
| Alteplase | 5 | 8.9 | 8.9 |
| Encorafenib | 3 | 8.1 | 8.1 |
| Copper | 6 | 3.7 | 3.7 |